KPIs & Operating Metrics(New)
Growth Metrics

Teva Pharmaceutical Industries (TEVA) Net Income towards Common Stockholders Growth (5y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 111.53 Bn 109.67 Bn -
2 Teva Pharmaceutical Industries 39.57 Bn 35.83 Bn 1.97 Bn
3 Zoetis 33.84 Bn 31.90 Bn 1.62 Bn
4 United Therapeutics 24.62 Bn 22.47 Bn 648.10 Mn
5 Aurora Cannabis 17.89 Bn 17.81 Bn 33.43 Mn
6 Neurocrine Biosciences 15.75 Bn 14.43 Bn 800.70 Mn
7 Regencell Bioscience Holdings 13.55 Bn 13.55 Bn -
8 Elanco Animal Health 10.61 Bn 10.18 Bn 785.00 Mn
9 HUTCHMED (China) 10.36 Bn 9.02 Bn -
10 Alkermes 6.14 Bn 5.63 Bn -116.06 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 19.23%
Dec 31, 2025 25.45%
Sep 30, 2025 15.98%
Jun 30, 2025 14.37%
Mar 31, 2025 25.29%
Dec 31, 2024 -35.48%
Sep 30, 2024 -17.79%
Jun 30, 2024 -9.41%
Mar 31, 2024 34.61%
Dec 31, 2023 44.56%
Sep 30, 2023 -13.14%
Jun 30, 2023 -45.34%
Mar 31, 2023 -24.17%
Dec 31, 2022 28.76%
Sep 30, 2022 -26.94%
Jun 30, 2022 29.26%
Mar 31, 2022 -39.36%
Dec 31, 2021 -1.48%
Sep 30, 2021 -14.87%
Jun 30, 2021 -14.87%
Mar 31, 2021 -28.96%
Dec 31, 2020 -20.92%
Sep 30, 2020 -113.37%
Jun 30, 2020 -23.63%
Mar 31, 2020 -31.15%
Dec 31, 2019 -30.68%
Sep 30, 2019 -18.30%
Jun 30, 2019 -23.42%
Mar 31, 2019 -16.15%
Dec 31, 2018 -54.62%
Sep 30, 2018 -19.37%
Jun 30, 2018 15.15%
Mar 31, 2018 7.38%
Dec 31, 2017 -127.91%
Sep 30, 2017 34.96%
Jun 30, 2017 -59.36%
Mar 31, 2017 -4.18%
Dec 31, 2016 -36.63%
Sep 30, 2016 1,222.87%
Jun 30, 2016 1,189.64%
Mar 31, 2016 -4.56%
Dec 31, 2015 -7.73%
Sep 30, 2015 -36.71%
Jun 30, 2015 -6.98%
Mar 31, 2015 -8.33%
Dec 31, 2014 14.12%
Sep 30, 2014 10.01%
Jun 30, 2014 9.45%
Mar 31, 2014 15.54%